Press releases

(May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS® Express2™...

(May 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR),...

and Chicago, IL (May 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results of four clinical trials demonstrating patient satisfaction with, and effectiveness of, the ENTERYX®

(May 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Banc of America Securities Health Care Conference 2005, which is being held May 17-19 in Las Vegas....

(April 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 30th Annual Health Care Conference, which is being held May 2-4 in Baltimore,...

(April 27, 2005) -- Boston Scientific (NYSE: BSX) today announced one-year data from its carotid artery stenting (CAS) clinical trial known as BEACH. The study evaluates the effectiveness of...

(April 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that six articles related to its pivotal TAXUS IV clinical trial were published in the April 19 edition of the...

(April 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its first quarter ended March 31, 2005. Highlights: Net sales of $1.6 billion, an increase of 49...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired TriVascular, Inc., a privately held company based in Santa Rosa, California. Boston Scientific...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has exercised its option to acquire CryoVascular Systems, Inc., a privately held company located in Los Gatos,...

(April 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is now acting as the exclusive distributor of the NexStent™ carotid stent and Monorail™ delivery system in...

(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Quincy, Massachusetts Customer Fulfillment Center has received the prestigious 2004 NorthFace ScoreBoardSM...

(April 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that enrollment has begun in its clinical trial known as SYNTAX, which will compare the performance of drug-eluting...

(April 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the Cadence Management Corporation 2004 Award for Customer Excellence in Project Management. This...

(April 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2005 on Tuesday, April 19, at 11:00...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SunTrust Robinson Humphrey's 34th Annual Institutional Conference which is being held April 11-12 at the...

(April 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for three large vessel sizes (4.0mm, 4.5mm and 5.0mm) of its TAXUS® Express2™...

(April 5, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved enhancements to the Directions for Use (DFU) of the...

(March 29, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the nationwide release of a revolutionary technology to treat chronic, debilitating pain, a condition affecting...

(March 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a jury in Delaware issued a verdict in a retrial of patent litigation between Boston Scientific and Johnson &...

(March 15, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Quincy Distribution Center as a...

(March 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Maple Grove, Minnesota manufacturing facility has received the 2005 Shingo Prize for Excellence in...

(March 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 25th Annual Health Care Conference, which is being held March 14 - 17 at the Marriott...

(March 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its three-year ENTERYX® Procedure clinical trial. The post-approval clinical trial...

and Orlando, FL (March 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed the results of Johnson & Johnson's REALITY clinical trial, which reaffirmed the safety and efficacy of...